And in the breast cancer clinical sample activated STAT5A/5B was positively correlated with the differentiation status of breast cancer, but it can also prevent the dissemination of confirmed breast cancer, which was a sign of good outcome for breast cancer with negative lymph nodes (48). The gene discussed is STAT5A; the disease is breast carcinoma.